Launching a community-wide effort to changethe odds against cancer in our hometown.
Sign up to receive updates on cancer news and research from the Cincinnati Cancer Center.
Through a shared vision to reverse this trend, the University of Cincinnati, UC Health and Cincinnati Children's Hospital Medical Center have formed the Cincinnati Cancer Center, a unique collaboration focused on breakthrough research.
We're focused on bringing the next generation of cancer treatments to all patients and all health systems in our community.
This will be done through dedicated study into the causes and cures for this disease, innovative drug development, and broad regional collaboration focused on reducing health disparities.
We have the drive to accelerate discovery. We are guided by rigorous research with a passion for innovation. From cellular mechanisms to survivorship and recovery, our investigators study every aspect of cancer.
We have the knowledge to advance the standard of care. With hundreds of researchers and faculty physicians leading our way, we are committed to excellence in care, collaboration and scholarship.
We have the vision to achieve the best outcomes. By setting our sights on tomorrow’s innovations, we’re utilizing the latest in medication and technology for multidisciplinary research and targeted treatment every day.
Ohio ranks as the seventh-worst state for cancer incidence and mortality.
Kentucky ranks as the worst state for cancer incidence and mortality per capita.
Our region is one of only two its size without a nationally designated cancer center.
More than 49,000 people in the Tristate died from cancer last year.
An internationally known scientist, Pier Paolo Scaglioni, MD, is in Cincinnati with a mission.
As a researcher, his focus is on leukemia lymphoma and lung cancer, and on the processes behind tumor formation and progression.
As a leader in academic medicine, he wants to see the development of new drugs and treatment protocols for patients.
That's why he came to the University of Cincinnati from University of Texas Southwestern. As Chief of the UC College of Medicine's Division of Hematology Oncology, his mission is to expand the college's bench of cancer-focused scientists.
With concentrated research excellence, he believes we can find the next round of breakthrough treatments right here in Cincinnati.
Cincinnati is on the map in terms of cancer biology.
Scaglioni, speaking to the to the Cincinnati Business Courier about translational research opportunities at the CCC. Read his full interview
At Cincinnati Children’s Hospital Medical Center, James Geller, MD, plays a key role in developing next-generation kidney tumor treatments.
As an international expert on solid tumors, his research and patient care focus also includes finding novel therapeutics for children and young adults affected by brain tumors, live tumors and retinoblastomas.
His work benefits patients not only at Cincinnati Children’s, but also at other top medical centers around the world.
At 31 years old and 4 months pregnant, Edgewood, KY, resident Whitney Hoffer was diagnosed with Hodgkin’s lymphoma.
Balancing the urgency of her treatment with protecting her pregnancy, Hoffer’s oncology team devised a multi-step plan of chemotherapy followed by proton radiation therapy—a unique and advanced form of radiation available at UC Health.
In the middle of her treatment, Hoffer delivered a healthy baby girl—and she’s been cancer free since spring of 2017.
In the lab of David Plas, PhD, UC researchers use the lessons learned in leukemia care to the problem of glioma, a stubbornly aggressive form of brain cancer.
By studying a protein involved in the chain of mutations that leads to glioma, Plas aims to move towards early, targeted intervention for this deadly form of cancer.
"Unfortunately, this approach has not yet been successful in brain cancer. We hope to bring some of the ideas from the world of leukemia research into brain cancer and see whether they can be successfully applied or modified."
A pioneer in studying the genetic underpinnings of melanoma, Dr. Zalfa Abdel-Malek is a nationally recognized researcher at UC’s College of Medicine.
Her translational, multidisciplinary research has received funding from the National Cancer Institute to support her overarching goal: the development of a topical skin cream that repairs the damage caused by the sun, and can prevent the development of skin cancer.
"Melanoma is the deadliest forms of skin cancer if not detected early and is responsible for 80 to 85 percent of skin cancer fatalities," Abdel-Malek says.
We're working at the cellular level to protect and repair the skin, which is the desired outcome that reduces UV-induced damage in the first place.
$1.4M VA grant will help UC researcher study radiation resistance in patients with head and neck cancers.
Andrew Porter becomes a Cincinnati Children's/UC Health Proton Therapy radiation therapist after his own experience with pediatric cancer and lifesaving proton therapy
Researchers find that stepping outside to smoke, or smoking in a room away from the kids, doesn’t prevent exposure
A far-reaching effort to genetically profile a collection of malignant peripheral nerve sheath tumors (MPNSTs) has identified a potential therapy...
Today's research will find tomorrow's cures.Thank you for joining us and supporting the science underway in Cincinnati. Together, cancer ends here.